Skip to main content

Published locations for Bimekizumab beneficial in PsA patients with inadequate response to or intolerance of TNFα inhibitors

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Bimekizumab beneficial in PsA patients with inadequate response to or intolerance of TNFα inhibitors

User login

  • Reset your password
  • /content/bimekizumab-beneficial-psa-patients-inadequate-response-or-intolerance-tnfa-inhibitors
  • /rheumatology/article/260151/psoriatic-arthritis/bimekizumab-beneficial-psa-patients-inadequate
  • /breast-cancer-icymi/article/260151/psoriatic-arthritis/bimekizumab-beneficial-psa-patients
  • /b-cell-lymphoma-icymi/article/260151/psoriatic-arthritis/bimekizumab-beneficial-psa-patients
  • /psoriatic-arthritis-icymi/article/260151/psoriatic-arthritis/bimekizumab-beneficial-psa-patients